Clinical Trials Directory

Trials / Unknown

UnknownNCT03631108

Feasibility Study and Preliminary Application Study on Iris OCTA

Feasibility Study and Preliminary Application Study on Noninvasive Iris Optical Coherence Tomography Angiography (OCTA)

Status
Unknown
Phase
Study type
Observational
Enrollment
4,000 (estimated)
Sponsor
Shanghai Eye Disease Prevention and Treatment Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens. The main outcomes are iris blood flow density and vascular density.

Detailed description

1. Feasibility study of iris OCTA technology 2. Establishment of iris OCTA database in normal population and analysis of related factors: (1) different sex; (2) different age; (3) different myopic diopter; (4) 24-hour diurnal changes from morning to night; (5) before and after mydriasis; (6) different blood pressure; (7) different intraocular pressure; (8) different blood glucose; (9) before and after exercise. (10) drinking water, tea, coffee and red wine. 3. Analysis of iris OCTA data related to eye diseases:(1) conjunctivitis; (2) glaucoma; (3) childhood myopia; (4) uveitis; (5) diabetic retinopathy; (6) retinal detachment; (7) fundus neovascularization. 4. Influence of commonly used ophthalmic drops on iris OCTA data. Observe the difference of iris OCTA test data before and after treatment: (1) conjunctivitis treated with levofloxacin antibiotics; (2) glaucoma treated with prostaglandins, adrenalines and receptor blockers; (3) childhood myopia treated with atropine drugs (4) uveitis treated with hormonal drugs. (5) diabetic retinopathy treated with vasodilator. 5. Effect on iris OCTA data before and after ophthalmic surgery. (1) cataract, phacoemulsification + intraocular lens implantation; (2) glaucoma, iridectomy; (3) fundus neovascularization, intraocular injection of anti-VEGF; (4) diabetic retinopathy, vitreous surgery.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOCTA (ZEISS)All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens.

Timeline

Start date
2018-10-01
Primary completion
2019-04-01
Completion
2019-06-01
First posted
2018-08-15
Last updated
2018-09-06

Source: ClinicalTrials.gov record NCT03631108. Inclusion in this directory is not an endorsement.